Primary care physicians see a lot of patients with cognitive decline and memory loss. Catching these patients early is key to reducing the risk of Alzheimer’s and other dementias. In fact, 1 in 3 cases of Alzheimer’s disease could be prevented by mitigating modifiable risk factors during early intervention.
The eVox System is an FDA 510(k) cleared medical device that may help physicians develop a more accurate and timely diagnosis for patients with memory loss and other cognitive disorders. It performs an objective, non-invasive assessment of brain function. And it is perfect for primary care and specialty physicians – no prior neuroscience expertise needed!
eVox measures EEG and Event-Related Potential (ERP) biomarkers to help physicians detect MCI sooner, differentiate dementia from pseudo-dementia, and evaluate cognition during annual wellness exams. The assessment is performed in-office by an MA or office staff. It takes 10 minutes for patient prep; 25 minutes for the test; 10 minutes between patients. And, it is reimbursable by Medicare and many commercial plans, on average $739 per assessment.
Timely detection of memory loss offers the opportunity of early intervention, prompt treatment of reversible causes, and cost savings. The eVox System may help doctors detect memory loss and MCI years earlier than the current standard of care.
Evoke Neuroscience offers representatives:
- Comprehensive training sessions (groups or one on one)
- Competitive compensation
- One-on-one support with all active prospects
- Assistance in closing and talking with prospective clients
- Could-based resource center (DropBox)
Evoke offers superior customer and technical support and aspires to create long lasting relationships with all of its doctors and partners. To find out more about adding this solution to your offer go to: https://everyancillary.com/find-ancillary-vendors/neurocognitive-assessments
Join us today!